Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar-Apr;48(2):220-243.
doi: 10.1590/S1677-5538.IBJU.2021.0098.

Neurogenic bladder - concepts and treatment recommendations

Affiliations
Review

Neurogenic bladder - concepts and treatment recommendations

José Carlos Truzzi et al. Int Braz J Urol. 2022 Mar-Apr.

Abstract

Introduction: Bladder and urinary sphincter malfunctioning that results from some change in the central and/or peripheral nervous system is defined as neurogenic bladder. The urinary tract symptoms that can be related to its filling, emptying, or both have a significant impact on the quality of life of individuals. The present review was based on the document prepared for the public health system in Brazil as a treatment guidelines proposal.

Material and methods: Survey questions were structured as per PICO (Population, Intervention, Control, and Outcome). Search strategies were defined and performed in the MEDLINE/Pubmed, Embase, Epistemonikos and Google Scholar databases. The selection of articles followed the evidence hierarchy concept; evidence body was identified, and the quantitative study data were extracted. The quality of evidence and grade of recommendation were qualitatively assessed according to GRADE (Grading of Recommendations, Assessment, Development and Evaluations).

Results: A total of 2.707 articles were identified, with 49 of them being selected to compose the basis for this review. Neurogenic bladder treatments were classified according to their focus on filling or emptying symptoms and sub- classified in pharmacological and surgical treatments.

Conclusion: Treatment guidelines are important tools for the public health system to promote the best practice when treating neurogenic bladder patients.

Keywords: Therapeutics; Urinary Bladder, Neurogenic; Urinary Sphincter, Artificial.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1. Functional classification of neurogenic voiding disorders: combination of detrusor - sphincter dysfunction secondary to damage to the innervation of the lower urinary tract that provides the basis for the current therapeutic concepts.
Figure 2
Figure 2. Muscarinic and adrenergic receptors of the bladder
Figure 3
Figure 3. Botulinum toxin injection sites into bladder. (Image courtesy of Allergan, an AbbVie company)
Figure 4
Figure 4. A) Enterocystoplasty procedure: open bladder (appearance of an open scallop or clam) with the Foley catheter and detubulized ileum segment being anastomosed to the bladder; B) Cystouretrography before the enterocystoplasty: trabeculated bladder with multiple diverticulae; C) Cystouretrography after the enterocystoplasty.

References

    1. Blok B, Castro-Diaz D, Del Popolo G, Groen J, Hamid R, Karsenty G, et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology 2020. [Internet]. Available at. <https://uroweb.org/guideline/neuro-urology/> - PubMed
    1. [No Authors] Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease. In: National Clinical Guideline Centre (UK). Royal College of Physicians. London (UK); Published by the National Clinical Guideline Centre. 2012; vol 1. pp. 47-311. - PubMed
    1. Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015; 14:720-32. - PubMed
    1. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia. 1990; 28:217-29. - PubMed
    1. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358:j4008. - PMC - PubMed